The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Interactions between physicians and the pharmaceutical industry generally and sales representatives specifically and their association with physicians’ attitudes and prescribing habits: a systematic review
Open accessAbstract
Objectives: The objective of this review is to explore interactions between physicians and the pharmaceutical industry including sales representatives and their impact on physicians’ attitude and prescribing habits. Data sources: PubMed, Embase, Cochrane Library and Google scholar electronic databases were searched from 1992 to August 2016 using free-text words and medical subject headings relevant to the topic. Study selection: Studies included cross-sectional studies, cohort studies, randomised trials and survey designs. Studies with narrative reviews, case reports, opinion polls and letters to the editor were excluded from data synthesis. Data extraction: Two reviewers independently extracted the data. Data on study design, study year, country, participant characteristics, setting and number of participants were collected. Data synthesis: Pharmaceutical industry and pharmaceutical sales representative (PSR) interactions influence physicians’ attitudes and their prescribing behaviour and increase the number of formulary addition requests for the company’s drug. Conclusion: Physician–pharmaceutical industry and its sales representative’s interactions and acceptance of gifts from the company’s PSRs have been found to affect physicians’ prescribing behaviour and are likely to contribute to irrational prescribing of the company’s drug. Therefore, intervention in the form of policy implementation and education about the implications of these interactions is needed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,451
GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables
Guyatt, G., Oxman, A. D., Akl, E. A., Kunz, R., Vist, G., Brozek, J., Norris, S., Falck-Ytter, Y., Glasziou, P., & deBeer, H. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.04.026 · Cited by 10,681
Physicians and the Pharmaceutical Industry: Is a Gift Ever Just a Gift?
Wazana, A. (2000) · JAMA · doi:10.1001/jama.283.3.373 · Cited by 1,415
Brennan, T. A., Rothman, D. J., Blank, L., Blumenthal, D., Chimonas, S. C., Cohen, J. J., Goldman, J., Kassirer, J. P., Kimball, H., Naughton, J., et al. (2006) · JAMA · doi:10.1001/jama.295.4.429 · Cited by 695
Spurling, G. K., Mansfield, P. R., Montgomery, B. D., Lexchin, J., Doust, J., Othman, N., & Vitry, A. I. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000352 · Cited by 526
DeJong, C., Aguilar, T., Tseng, C.-W., Lin, G. A., Boscardin, W. J., & Dudley, R. A. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.2765 · Cited by 517
Chren, M. M. (1994) · JAMA · doi:10.1001/jama.271.9.684 · Cited by 397
The Effects of Pharmaceutical Firm Enticements on Physician Prescribing Patterns
Orlowski, J. P., & Wateska, L. (1992) · Chest · doi:10.1378/chest.102.1.270 · Cited by 384
Steinman, M. A., Shlipak, M. G., & McPhee, S. J. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)00660-x · Cited by 383
The Accuracy of Drug Information From Pharmaceutical Sales Representatives
Ziegler, M. G. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03520400066047 · Cited by 297
Interactions between physicians and the pharmaceutical industry: what does the literature say?
Lexchin, J. (1993) · Europe PMC (PubMed Central) · Cited by 271
Following the Script: How Drug Reps Make Friends and Influence Doctors
Fugh-Berman, A., & Ahari, S. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040150 · Cited by 233
Yeh, J. S., Franklin, J. M., Avorn, J., Landon, J., & Kesselheim, A. S. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.1709 · Cited by 218
A comparison of physicians’ and patients’ attitudes toward pharmaceutical industry gifts
Gibbons, R. V., Landry, F. J., Blouch, D. L., Jones, D. L., Williams, F. K., Lucey, C. R., & Kroenke, K. (1998) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.1998.00048.x · Cited by 197
Interactions between pharmaceutical representatives and doctors in training: A thematic review
Zipkin, D. A., & Steinman, M. A. (2005) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2005.0134.x · Cited by 167
Physicians, pharmaceutical sales representatives, and the cost of prescribing
Caudill, T. S. (1996) · Archives of Family Medicine · doi:10.1001/archfami.5.4.201 · Cited by 166
Physicians and Drug Representatives: Exploring the Dynamics of the Relationship
Chimonas, S. C., Brennan, T. A., & Rothman, D. J. (2007) · Journal of General Internal Medicine · doi:10.1007/s11606-006-0041-z · Cited by 164
Pharmaceutical representatives in academic medical centers
Lurie, N., Rich, E. C., SIMPSON, D. E., Meyer, J., Schiedermayer, D. L., Goodman, J. L., & McKinney, W. P. (1990) · Journal of General Internal Medicine · doi:10.1007/bf02600542 · Cited by 154
Hodges, B. D. (1995) · PubMed · Cited by 142
Lieb, K. P., & Scheurich, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110130 · Cited by 140
Are Gifts From Pharmaceutical Companies Ethically Problematic? A Survey of Physicians
Brett, A. S., Burr, W., & Moloo, J. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.18.2213 · Cited by 136
Interactions of doctors with the pharmaceutical industry
Morgan, M., Dana, J. D., Loewenstein, G. F., Zinberg, S., & Schulkin, J. A. (2006) · Journal of Medical Ethics · doi:10.1136/jme.2005.014480 · Cited by 127
Kesselheim, A. S., Mello, M. M., & Studdert, D. M. (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1000431 · Cited by 112
Prescribers and Pharmaceutical Representatives: Why Are We Still Meeting?
Fischer, M. A., Keough, M. E., Baril, J. L., Saccoccio, L., Mazor, K. M., Ladd, E., Worley, A. V., & Gurwitz, J. H. (2009) · Journal of General Internal Medicine · doi:10.1007/s11606-009-0989-6 · Cited by 89
Grande, D. (2009) · Journal of General Internal Medicine · doi:10.1007/s11606-009-1016-7 · Cited by 84
Lieb, K. P., & Brandtönies, S. (2010) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2010.0392 · Cited by 83
Pr, L. (1992) · Archives of Internal Medicine · doi:10.1001/archinte.152.5.1009 · Cited by 83
Gifts to Physicians From Industry
Goldstein, A. O. (1991) · JAMA · doi:10.1001/jama.1991.03470010065014 · Cited by 81
Japanese Practicing Physicians' Relationships with Pharmaceutical Representatives: A National Survey
Saito, S., Mukohara, K., & Bito, S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012193 · Cited by 80
When pharmaceutical manufacturersʼ employees present grand rounds, what do residents remember?
Spingarn, R. W., Berlin, J. A., & Strom, B. L. (1996) · Academic Medicine · doi:10.1097/00001888-199601000-00022 · Cited by 72
Interactions between Non-Physician Clinicians and Industry: A Systematic Review
Grundy, Q., Bero, L. A., & Malone, R. E. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001561 · Cited by 51
Attitudes of general practitioners in New Zealand to pharmaceutical representatives.
Thomson, A. N., Craig, B. J., & Barham, P. M. (1994) · Europe PMC (PubMed Central) · Cited by 50
Larkin, I., Ang, D., Avorn, J., & Kesselheim, A. S. (2014) · Health Affairs · doi:10.1377/hlthaff.2013.0939 · Cited by 50
Influence of Medical Representatives on Prescribing Practices in Mekelle, Northern Ethiopia
Workneh, B. D., Gebrehiwot, M. G., Bayou, T. A., Gidey, M. T., Belay, Y. B., Tesfaye, D. M., & Kassa, T. T. (2016) · PLoS ONE · doi:10.1371/journal.pone.0156795 · Cited by 46
Wall, L. L., & Brown, D. (2007) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000268800.46677.14 · Cited by 44
Othman, N., Vitry, A. I., Roughead, E. E., Ismail, S. B., & Omar, K. (2010) · BMC Public Health · doi:10.1186/1471-2458-10-743 · Cited by 44
Ferrari, A. D., Sanchez, C. G., Davalos, L., Huayanay, L., & Málaga, G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100114 · Cited by 44
Industry Relationships With Pediatricians: Findings From the Open Payments Sunshine Act
Parikh, K., Fleischman, W. M., & Agrawal, S. (2016) · PEDIATRICS · doi:10.1542/peds.2015-4440 · Cited by 43
Chressanthis, G. A., Khedkar, P., Jain, N., Poddar, P., & Seiders, M. G. (2012) · Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2012.00651.x · Cited by 41
Esmaily, H. M., Silver, I., Shiva, S., Gargani, A., Maleki‐Dizaji, N., Al-Maniri, A., & Wahlström, R. (2010) · Journal of Continuing Education in the Health Professions · doi:10.1002/chp.20051 · Cited by 40
A survey of pharmaceutical company representative interactions with doctors in Libya
Alssageer, M. A., & Kowalski, S. R. (2012) · Libyan Journal of Medicine · doi:10.3402/ljm.v7i0.18556 · Cited by 37
Wolfe, S. M. (1996) · Journal of General Internal Medicine · doi:10.1007/bf02599033 · Cited by 36
Lotfi, T., Morsi, R. Z., Rajabbik, M. H., Alkhaled, L., Kahale, L. A., Nass, H., Brax, H., Fadlallah, R., & Akl, E. A. (2016) · BMC Health Services Research · doi:10.1186/s12913-016-1299-4 · Cited by 31
Carroll, A. E., Vreeman, R., Buddenbaum, J. L., & Inui, T. S. (2007) · PEDIATRICS · doi:10.1542/peds.2007-0363 · Cited by 29
Kamal, S., Holmberg, C., Russell, J., Bochenek, T., Tobiasz‐Adamczyk, B., Fischer, C., & Tinnemann, P. (2015) · PLoS ONE · doi:10.1371/journal.pone.0140457 · Cited by 27
Gupta, S. K., Nayak, R., & Sivaranjani, R. (2015) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/0975-7406.171695 · Cited by 27
Everything you need to know about the Sunshine Act
Silverman, E. (2013) · BMJ · doi:10.1136/bmj.f4704 · Cited by 26
Pharmaceutical industry interactions of psychiatric trainees from 20 European countries
Riese, F., Gülöksüz, S., Roventa, C., et al. (2014) · European Psychiatry · doi:10.1016/j.eurpsy.2014.09.417 · Cited by 26
Unhealthy marketing of pharmaceutical products: An international public health concern
Mulinari, S. (2016) · Journal of Public Health Policy · doi:10.1057/jphp.2016.6 · Cited by 24
Interactions with industry under the Sunshine Act: an example from gynecologic oncology
Shalowitz, D. I., Spillman, M. A., & Morgan, M. A. (2016) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2016.02.035 · Cited by 22
Yeh, J. S.-J., Austad, K., Franklin, J. M., Chimonas, S. C., Campbell, E. G., Avorn, J., & Kesselheim, A. S. (2014) · PLoS Medicine · doi:10.1371/journal.pmed.1001743 · Cited by 18
Physicians' attitudes towards interaction with the pharmaceutical industry
Alosaimi, F. D., Kaabba, A. A., Qadi, M., Albahlal, A., Alabdulkarim, Y., Alabduljabbor, M., & Alqahtani, F. (2014) · Eastern Mediterranean Health Journal · doi:10.26719/2014.20.12.812 · Cited by 18
Montastruc, F., Moulis, G., Palmaro, A., Gardette, V., Durrieu, G., & Montastruc, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104828 · Cited by 17
Determinants of pharmaceutical sales representative access limits to physicians
Chressanthis, G. A., Sfekas, A., Khedkar, P., Jain, N., & Poddar, P. (2014) · Journal of Medical Marketing Device Diagnostic and Pharmaceutical Marketing · doi:10.1177/1745790415583866 · Cited by 17
Brown, S. R., Evans, D., & Fugh‐Berman, A. (2015) · PubMed · Cited by 14
Greenland, P. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.72 · Cited by 13
Physician report of industry gifts and quality of care
Lee, D., & Begley, C. E. (2014) · Health Care Management Review · doi:10.1097/hmr.0000000000000042 · Cited by 13
Controlling Quality in CME/CPD by Measuring and Illuminating Bias
Dixon, D., Takhar, J., Macnab, J. J., Eadie, J., Lockyer, J., Stenerson, H., François, J., Bell, M. J., Monette, C., Campbell, C., et al. (2011) · Journal of Continuing Education in the Health Professions · doi:10.1002/chp.20114 · Cited by 10
Scheffer, M. C. (2014) · Sao Paulo Medical Journal · doi:10.1590/1516-3180.2014.1321609 · Cited by 8
Cited by
Mitchell, A. P., Trivedi, N. U., Gennarelli, R. L., Chimonas, S., Tabatabai, S. M., Goldberg, J., Diaz, L. A., & Korenstein, D. (2021) · Annals of Internal Medicine · doi:10.7326/m20-5665 · Cited by 262
Metadata
- Authors
- Fickweiler, F., Fickweiler, W., & Urbach, E.
- Venue
- BMJ Open
- Publisher
- BMJ
- Published
- 2017-09
- Volume
- 7
- Issue
- 9
- Pages
- e016408
- ISSN
- 2044-6055 (ISSN-L)
- OpenAlex
- W2759900990
- Cited by
- 293
- References
- 60
- FWCI
- 6.27
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.